The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy

The International prognostic Index (IPI) is the most widely used clinical prediction model for diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP), but may be suboptimal in older patients. We aimed to develop and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Isaksen, Kathrine T., Galleberg, Renate, Mastroianni, Maria Adele, Rinde, Marit, Rusten, Leiv Sindre, Barzenje, Dlawer, Ramslien, Frode, Fluge, Øystein, Slaaen, Marit, Meyer, Peter, Liestøl, Knut, Smeland, Erlend B., Lingjærde, Ole Christian, Holte, Harald, Brodtkorb, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Article - Non-Hodgkin Lymphoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483351/
https://www.ncbi.nlm.nih.gov/pubmed/36861406
http://dx.doi.org/10.3324/haematol.2022.282289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483351/
https://www.ncbi.nlm.nih.gov/pubmed/36861406
http://dx.doi.org/10.3324/haematol.2022.282289

Ejemplares similares